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Multiple infectious Agents and 
the Origins of Atherosclerotic 
Coronary Artery Disease
James S. Lawson*
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia
Although deaths due to atherosclerotic coronary artery disease (ACAD) have fallen dra-
matically during the past 50 years, ACAD remains as the leading cause of death in all 
continents, except Africa, where deaths due to infections are still dominant. Although food 
and nutrition have a proven role in atherosclerosis, the underlying causes of ACAD remain 
unknown. This is despite a century of intensive research dominated by investigations into 
the saturated fat hypothesis. In this review, it is hypothesized that the rise and fall in ACAD 
during the past 100 years is primarily due to the parallel rise and fall in the prevalence 
of coronary atheroma, the underlying disease. It is further hypothesized that infectious 
pathogens initiate atherosclerosis mainly during infancy and childhood. It is speculated 
that widespread use of antibiotics and vaccines against bacterial and viral infections 
may be the reason for the dramatic fall in coronary atheroma and ACAD during the past 
50 years. The relevant evidence and a working hypothesis are included in this review.
Keywords: atherosclerosis, coronary disease, infectious pathogens, diet and nutrition, coronary atheroma, trends
Chlamydia pneumoniae, cytomegalovirus, hepatitis C, Epstein Barr virus, human papilloma virus, 
human immunodeficiency virus, enterobacteriaceae, and other infectious pathogens may initiate 
atherosclerotic vascular diseases.
HYPOTHeSiS
The main risk factors for atherosclerotic coronary artery disease (ACAD) are genetics, abnormal 
blood lipids, hypertension, diabetes, tobacco smoking, and glucose intolerance. In addition to 
these well-documented risk factors, it is hypothesized that (i) ACAD is initiated by multiple 
infectious pathogens, (ii) these pathogens have adverse influences on the endothelial lining and 
smooth muscle cells of blood vessels, which lead to inflammation of the vascular system, (iii) some 
pathogens influence lipid metabolism, (iv) several pathogens may live in the vascular system for 
decades and cause atheroma, (v) there is an influence of food on these pathogens and the formation 
of atheroma, and (vi) total food consumption has an additional independent influence on ACAD.
BACKGROUND
Atheroma or atherosclerosis is a chronic inflammatory disease of the arterial wall (1). Atherosclerosis 
in arterial walls is characterized by the invasion and accumulation of white blood cells, which trans-
form into macrophages. Macrophages ingest lipids becoming “foam” cells. Concurrently, there is 
proliferation of vascular smooth muscle cells, resulting in the creation of fibrofatty plaques. These 
changes result in thickening of the walls of arteries. The early signs of atherosclerosis are fatty streaks 
lining the arteries, which years later, develop into plaques. These plaques may rupture and induce 
FiGURe 1 | Advanced atheroma in the coronary artery of a  
17–year-old girl (13).
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rose from approximately 140 per 100,000 population in 1900 to 
a peak of 355 in 1960 followed by a remarkable decline to 170 in 
2010 (15). These data are based on variations of the diagnosis of 
heart disease and must be regarded as trends rather than precise 
figures. However, the historical data are broadly in line with more 
recent data based on specific diagnoses of coronary artery disease 
and age-adjusted annual death rates per 100,000 of the total US 
population (16). These later data indicated a 76% decline during 
the past 50 years (16).
In addition to this pattern of deaths due to coronary artery 
disease, there has been an equally dramatic fall in the prevalence 
of atheroma of the coronary arteries. This is also shown in 
Figure 2. The data in Figure 2 are based on the direct observa-
tion of coronary arteries during autopsies conducted on soldiers 
killed in wars over a 100-year period. These autopsies clearly 
demonstrate coronary atheroma in physically fit young men 
(average age 22–27  years) from Germany (First World War – 
1915) and the US (Korea 1950–1953, Vietnam 1964–1975, Iraq 
and Afghanistan 2001–2011) (9–12). These data are shown in 
more detail in Table 1.
The data based on each war period are not strictly comparable 
due to different diagnostic criteria and autopsies conducted by 
different pathologists. Therefore, the validity of the data, based 
on autopsies of soldiers over a 100-year period, needs to be 
considered. First, the diagnosis of coronary atheroma by gross 
observation and light microscopy is not difficult and is reason-
ably consistent. Second, the prevalence of coronary atheroma 
based on autopsies in male soldiers in 1950–1953 was broadly 
similar to that observed in military pilots in 1980–1982 (17) 
and to those made on US civilians between 1950 and 1994 (18). 
Among the military pilots, Booze and Staggs observed a fall of 
severe coronary atherosclerosis from 5 to 2.5% between 1975–77 
and 1980–82 (17). Third, based on uniform autopsy techniques 
in studies conducted in New Orleans, the extent and prevalence 
of atherosclerotic lesions in the coronary arteries and aortas of 
deceased 25- to 44-year-old white men significantly decreased 
thrombus formation in the lumen of an artery, which may lead 
to thromboembolism or arterial occlusion with consequent 
coronary ischemia and death (1).
There is sound evidence that atherosclerosis is initiated in 
infancy and childhood and is associated with childhood infec-
tions that develop later age atheroma (2–5). Autopsy based data 
have shown that ACAD can begin in the perinatal period and 
early childhood and can be well established by the teenage years 
(2, 3, 6, 7). Several of these studies are based on retrospective 
observations of the same subjects over a 30-year period and 
indicate that there may be an over two times increased risk of 
cardiovascular disease in adulthood following a serious (suf-
ficient to cause hospitalization) childhood infection (4, 5). The 
identification of specific pathogens was not made in these stud-
ies. Many Western children may have early and even advanced 
atheroma at ages 12–14 years (2, 3, 7, 8). Autopsy-based studies of 
young US white and black subjects, killed between 1987 and 1994 
because of accidental trauma or homicide, have demonstrated 
that over half of the right coronary artery of the youngest age 
group (15–19 years) had atheromatous lesions (8). This is similar 
to the coronary atheroma lesions observed in young (average 
age 22–27 years) German (1914) killed in World War I and US 
soldiers killed in the Korean (1951–1953), Vietnam (1965–1975), 
and the Afghanistan and Iraq wars (2001–2011) (9–12).
Advanced atheroma of a coronary artery in a 17-year-old girl 
is shown in Figure 1.
Trends in the Prevalence of 
Atherosclerosis and the Search for the 
Underlying Causes of Atherosclerosis
The rise and fall in the number of deaths due to ACAD over the 
past 100  years in the US is typical of other Western countries 
including the United Kingdom, Germany, and Australia (14). 
Data from the US are of special value as they are available for over 
100 years. As shown in Figure 2, deaths in the US due to ACAD 
FiGURe 2 | Deaths due to coronary artery disease USA (blue columns). Coronary atheroma prevalence (red line). 100-year trends (9–12, 15). 
TABle 1 | Prevalence of atheromatous coronary artery disease in young western soldiers (over 98% males) killed in world war i, Korea, vietnam, iraq, 
and Afghanistan (9–12).
Age groups  
deceased soldiers
1915 world war i n = 171  
(mostly German soldiers) (i)
1950–1953 Korea n = 300  
(US soldiers) (ii)
1964–1975 vietnam n = 105  
(US soldiers) (iii)
2001–2011 iraq and Afghanistan 
n = 3,832 (US soldiers) (iv)
<25 years 22/50 (44%) na na 135/2,047 (7%)
25–29 years 23/47 (49%) na na 103/931 (11%)
30–39 years 21/35 (60%) na na 154/697 (22%)
40+ years 26/39 (67%) na na 72/157 (46%)
Average age 29 years 22 years 22 years 26 years
Atheroma all  
ages (%)
92/171 (54%) 232/300 (77%) 47/105 (45%) 464/3,832 (12% aorta + coronary; 
9% coronary)
The age specific data, based on autopsies of soldiers killed in World War I and in the Afghanistan and Iraq wars, are of particular interest because of the clear demonstration that the 
prevalence of coronary atheroma increases markedly with age.
na, not available.
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between 1960–64 and 1969–78 (19). These declines were not 
observed among same aged black men. Fourth, and also based 
on a uniform system of autopsy techniques, the prevalence of 
coronary atheroma among men and women below the age of 
60 years decreased from 38 to 27% during the period 1979–1994 
in Olmsted County, MN, USA (20). There was a further 
decline in coronary atheroma of approximately 20% among the 
same population between 1995 and 2012 (15). The decline in 
prevalence of coronary atheroma in Olmsted County was greater 
among young as compared to older citizens. The rate of decline 
in coronary atheroma has slowed in recent years (15). Because 
these data are based on a wide range of age groups, they are not 
directly comparable to the age-specific data based on US soldiers. 
However, the decline in coronary atheroma demonstrated by the 
New Orleans and Olmsted autopsy-based data parallels and adds 
validity to the US soldier-based data (15, 19). Overall, the data 
from different sources are consistent, particularly with respect 
to the decline in prevalence of coronary atheroma among young 
men. It is concluded that the decline in coronary atheroma is real 
and not due to different methods of assessing autopsy findings.
The rise and fall in the prevalence of coronary atheroma 
closely parallels the prevalence of deaths due to coronary artery 
disease in the US during the same periods of time (see Figure 2) 
(15). This decline in deaths due to ACAD is in part due to 
a reduction in risk factors and improvements in surgical and 
medical treatments. However, as hypothesized in this review, 
it is likely that the decline in the underlying disease, namely 
atherosclerosis, has been the dominant factor. The fall in deaths 
due to coronary artery disease by approximately two-thirds dur-
ing the past 50 years has occurred in all Western countries (21). 
The epidemiological trends of deaths due to coronary artery 
disease are different in Eastern European, South American, and 
Asian populations (21). The pattern of a dramatic rise and fall 
in deaths is typical of an infectious-based disease.
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It should be noted that (i) different methodologies and 
assessments by pathologists over a 100-year period apply to 
the atheroma autopsy-based studies (red line) and (ii) different 
criteria apply to the deaths attributed to coronary artery disease 
(blue columns). Accordingly, these data indicate trends and not 
precise measurements.
infectious Pathogens
The classic risk factors for atherosclerosis are well established 
(22, 23). These risk factors include excess body weight, dyslipi-
demia, hypertension, tobacco smoking, genetics, diabetes, and 
glucose intolerance. An important feature of atherosclerosis is 
the marked increase in prevalence associated with increased age. 
This indicates an ongoing chronic process.
In addition to these risk factors is the likely role of infectious 
pathogens. The first experimental evidence that infectious patho-
gens could cause atherosclerosis in blood vessels was developed 
by Fabricant et al. in 1978 (24). They demonstrated that Marek’s 
herpes virus could cause atherosclerosis in chickens. Infection 
with this herpes virus was required to induce atherosclerosis 
whether or not the chickens were fed a high or low cholesterol 
diet. They also demonstrated that infections with these herpes 
viruses altered intracellular lipid metabolism (25). Importantly, 
this infectious phenomenon could be prevented by vaccination 
(26). These observations of atherosclerosis in chickens closely 
resemble atherosclerosis in humans and are a key to the hypoth-
esis that infectious pathogens may have a causal role in vascular 
atherosclerosis in humans (26).
A number of herpes viruses have been identified in 
atherosclerotic coronary arteries and normal vascular struc-
tures in humans. These herpes viruses include Epstein–Barr 
virus (EBV) (human herpes virus 4), Cytomegalovirus (CMV) 
(human herpes virus 5), and herpes simplex virus (HSV) 
(human herpes virus 1 and 2) (13, 27, 28). Infections with EBV 
and other herpes viruses are associated with atherogenic lipid 
changes (29–32).
Multiple additional pathogens in both normal and atheroscle-
rotic blood vessels have been identified (33, 34). The pathogens 
identified in normal blood vessels by a species-specific approach 
include Chlamydia pneumoniae (Cp), Helicobacter pylori, 
Mycoplasma pneumoniae, CMV, hepatitis C, HSV, EBV, human 
papilloma virus (HPV), and human immunodeficiency virus 
(HIV) (13, 27, 35, 36). There is an extensive list of additional 
pathogens, which have been identified in atherosclerotic plaques 
by massive computerized gene sequencing (34). These include the 
pathogen families, such as porphyromonadaceae, bacteroidaceae, 
micrococcaceae, streptococcaceae plus viruses such as EBV 
and HPVs. The importance of these observations is (i) they 
demonstrate that the long held view that blood vessels were 
sterile is incorrect and (ii) that pathogens in blood vessels are 
not necessarily parasites, which infect atheromatous plaques.
epidemiological evidence for a Role of 
infectious Pathogens in Atherosclerosis
There is epidemiological evidence, which is supportive of a role 
by several specific pathogens in atherosclerosis.
Periodontal Porphyromonas gingivalis
Pathogens associated with periodontal infections have been 
extensively studied. A higher periodontal pathogen load with 
Porphyromonas gingivalis has been identified in patients with 
atherosclerotic vascular disease as compared to controls (33, 37).
Human Papilloma Virus
Women with HPV genital infections have up to threefold 
increased risk of atherosclerotic vascular disease (38), and high 
risk for cancer HPVs have been identified in atheromatous 
plaques and in coronary artery smooth muscle cells (13). There 
is experimental evidence that human aortic smooth muscle cells 
proliferate when exposed to HPVs (39).
Chlamydia pneumoniae
There are many studies, which confirm the presence of Cp in 
atheroma plaques (40). In a large study of Japanese men and 
women, high levels of serum antibodies to Cp were associated 
with a doubling of the prevalence of ACAD (41). These findings, 
suggesting a role for Cp in atherosclerosis, have been supported 
by recent experiments, which show that a single infection of Cp is 
sufficient to exacerbate atherosclerosis in mice (42).
Enterobacteriaceae
There is a possible link between the identification of enterobacte-
riaceae in vascular atherosclerotic lesions and serious childhood 
infections with later adult ACAD (4, 5, 43). This is because many 
serious childhood infections are caused by enterobacteriaceae in 
the renal tract.
infections and Chronicity
It is possible that chronic infections may have a role in the 
marked increase in the prevalence of ACAD between the ages 
of 20 and 40 years. This increase in ACAD associated with age 
was clearly demonstrated by the study of atherosclerosis in US 
soldiers killed in the Iraq and Afghanistan wars (12). While the 
reasons are not known, Cp has the capacity to cause inflamma-
tion over decades of time. Similarly, high risk for cancer HPVs 
may cause persistent inflammation and a tripling of the risk of 
ACAD in women (13, 38). CMV and EBV also have the capacity 
to persist over decades (35, 44).
Microbiota
Microbiota refers to the hundreds of different bacteria and 
viruses that are located throughout the body. The largest and 
most diverse microbiota location is the gut. While the evidence 
is not definitive that the gut or other microbiota influence the 
development of atherosclerosis, there is substantial evidence in 
support of this notion (45, 46). There are different microbiotas 
in different locations, including the genital tract, blood, and even 
atherosclerotic plaques (46). On the other hand, atherosclerotic 
plaques, the gut, and periodontal locations can have similar 
microbiota in the same patients (46). This microbiota can be 
dominated by Escherichia coli (46). This suggests that there may 
be similar biological influences in these very different locations. 
The composition of the gut microbiota is influenced by diet and 
infectious pathogens and also by antibiotics (47, 48).
TABle 2 | Asian (South Korea, Japan) and western (Australia, United 
Kingdom, US) apparent daily per capita food consumption in kilocalories 
1954/1961 and 2006/2008 and age-adjusted death rates per 100,000 
population due to coronary artery disease 1993 and 2014 (61, 62).
Daily 
kilocalories 
1954/1961
Daily 
kilocalories 
2006/2008
Deaths  
coronary artery 
disease 1993
Deaths 
coronary artery 
disease 2014
South 
Korea
2,141 3,040 13.5 26.4
Japan 2,070 2,800 21.5 30.4
Australia 3,230 3,220 112.6 54.9
United 
Kingdom
2,570 3,450 118.9 60.1
US 3,150 3,800 107.5 78.0
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Of particular interest is the relationship between viruses and 
bacteria in the gut (49). Several viruses, including noroviruses 
(the cause of 85% of gastroenteritis cases), mouse mammary 
tumor virus (the cause of breast cancer in mice and other 
mammals probably including humans), poliomyelitis virus, 
reovirus (the cause of respiratory and gastrointestinal infec-
tions), each require the co-location of bacteria in the gut to 
allow these viruses to enter cells (49). The special interest is 
because in experiments in which these viruses were exposed to 
antibiotics that inhibited gut bacteria, these viruses could not 
enter the target cells (49). This is relevant to the hypothesis that 
antibiotics may be one reason for the decline in the prevalence 
of atherosclerosis.
Food
For over 50  years, food consumption patterns have been the 
dominant causal hypothesis for vascular atheroma. Overall, the 
epidemiological studies on humans and the experimental studies 
on animals offer consistent observations that food consumption 
patterns are associated with coronary artery disease. The caution 
expressed decades ago by Marmot and Syme (50) and Truett et al. 
(51), that ACAD had more complicated origins than simply diet, 
was especially farsighted because at the time of their writing, it 
was not known that pathogenic infections could cause changes 
in lipid metabolism.
There has been a dominance of the saturated fat and coronary 
heart disease hypothesis. This is mainly due to the studies and 
promotion by Keys and his colleagues (52). This hypothesis was 
based on Keys’ famous Seven Country Study, which demonstrated 
that coronary heart disease was most common in Western dairy 
and red-meat eating countries and was associated with high blood 
lipid levels (52). During the same period, prospective studies were 
conducted in the town of Framingham in the US (53). These stud-
ies showed that high blood pressure, high blood cholesterol levels, 
obesity, and tobacco smoking were associated with increased risk 
of coronary artery disease (53). Despite the clear statements from 
the Framingham research group that evidence was not available 
upon which to base action, for the next 50 years, the views of the 
Ancel Keys research group became the basis of formal dietary 
guidelines in most Western countries. These guidelines included 
dogmatic advice for citizens of Western countries to reduce 
consumption of saturated fats, including most dairy foods. The 
assumption by the Ancel Keys group that a reduction in dietary 
saturated fats on a population basis would lead to a reduction in 
serum cholesterol is flawed. This is because cholesterol synthesis 
is regulated by a system of enzymes, which maintain the body’s 
cholesterol levels within a narrow range. When saturated fat 
intake increases, endogenous cholesterol production decreases. 
When the intake of saturated fat is decreased, endogenous pro-
duction increases to maintain serum cholesterol levels relatively 
constant (54). It should be noted that while it is possible to lower 
serum cholesterol in individuals by diet, the required diets are so 
severe that they are not sustainable.
The findings of these early studies, which demonstrated the 
influence of food consumption patterns on atherosclerosis, 
have been repeatedly confirmed. However, many studies sought 
to emphasize a potential harmful role of saturated fats. This 
emphasis has been shown to be misleading, and there is now 
a substantial body of evidence available that demonstrates the 
limited role of saturated fats in atherosclerosis (55–58). The 
recent Cochrane Collaboration (59) review of the evidence 
relevant to this issue concluded “…cutting down on saturated 
fat led to a 17% reduction in the risk of cardiovascular disease 
(including heart disease and strokes) but no effect on the risk 
of dying.”
On the other hand, there is compelling epidemiological 
evidence that total food consumption, as distinct from specific 
components of food, is associated with the prevalence of ACAD. 
In both low and high risk for ACAD countries, an increase in 
the body mass index is positively associated with increased inci-
dence of ACAD (22). Of particular interest is the recent 40-year 
prospective nationwide study of approximately 2.5 million Israeli 
adolescents, which demonstrated that overweight Israeli teenag-
ers were almost twice as likely and obese teenagers were up to 
five times as likely to have a fatal heart attack or stroke during 
middle age (60).
For over five decades, there has been a consistent associa-
tion between total per capita food consumption and ACAD in 
both low and high risk for ACAD countries. This is shown in 
Table 2. In 1961, the daily apparent consumption of calories in 
South Korea was 2,141 as compared to over 3,000 in US, which 
positively correlates to the 1993 death rates due to coronary artery 
disease of 13.5 in South Korea as compared to 107.5 per 100,000 
total population in the US (61, 62). As also shown in Table 2, 
these trends have persisted to the present time with a doubling of 
deaths associated with coronary artery disease in Korea, associ-
ated with a marked increase in food consumption. By way of 
contrast, death rates due to coronary artery disease have halved in 
Australia, the United Kingdom, and the US, despite only modest 
increases in food consumption.
The prevalence of ACAD based on autopsy findings among 
Japanese living in Hawaii and California is up to 3.5 times more 
frequent and more severe than Japanese living in Japan (63, 64). 
Serum cholesterol was significantly higher in the Japanese 
Hawaiians and Californians. However, as Marmot observed, 
when Japanese men ate equivalent diets in the three places, the 
Japanese Americans still had higher serum cholesterols than the 
Japanese in Japan (50). The implication being that serum choles-
terol is due to factors other than fat consumption.
TABle 3 | influence of pathogens on human and experimental animal lipid 
metabolism.
Pathogen Abnormal lipid 
metabolism  
humans
Abnormal lipid 
metabolism 
experimental animals
Chlamydia pneumonaie + +
Porphyromonas gingivalis + na
Epstein–Barr virus + na
Hepatitis C + na
Cytomegalovirus + na
Helicobacter pylori + na
Human papilloma virus + na
Enterobacter coli na na
Marek’s herpes virus na +
Herpes viruses + na
Human immunodeficiency virus + na
+, disruption or abnormal lipid metabolism, na, data not available.
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The patterns of food consumption in the US offer important 
support for the view that the components of diets, such as 
saturated fats and cholesterol, have little association with the 
prevalence of atheromatous coronary artery disease. These pat-
terns are shown in Table S1 in Supplementary Material. In the 
US, during the past 50 years, food energy has increased by 25%, 
protein consumption by 32%, and total fats by 38%. Consumption 
of cholesterol and added sugars has been stable. The overall pat-
terns of food consumption shown in Table S1 in Supplementary 
Material parallel the high prevalence of obesity in the US. During 
this same period, the consumption of saturated fats increased by 
approximately 10% (Table S1 in Supplementary Material). These 
US food consumption trends are opposite to what would have 
been expected if the saturated fat and atheroma hypothesis had 
been true.
MeCHANiSMS
infectious Pathogens
There are several excellent reviews of the role of infectious 
pathogens and atherosclerosis by Epstein et  al., Campbell and 
Rosenfeld, Feingold and Grunfeld, and Clifford and Hoffman 
(65–68). These reviews, plus additional material, have been used 
to explore the underlying mechanisms of infections and athero-
sclerosis as outlined below.
Multiple infectious pathogens contribute to acute and chronic 
inflammation of the vascular system (66). Although the evidence 
is not entirely consistent, infections of vascular wall cells lead to 
inflammation and atherosclerosis. The specific mechanisms differ 
between various pathogens. Both CMV and Cp appear to induce 
proliferation of vascular smooth muscle cells by inhibition of 
the tumor suppression gene p53 (69, 70). CMV, Cp, and HSV 
can each have an atherogenic effect, including smooth muscle 
proliferation, increased expression of cytokines, chemokines, and 
an increased uptake of low density lipoprotein (71).
There also appear to be infectious pathogen-associated 
autoimmune mechanisms associated with atherosclerosis. These 
mechanisms are complex and involve the increased expression 
of heat shock proteins (HSPs) in response to stress, such as 
infections. In some circumstances, these proteins may appear as 
“foreign” and engender an autoimmune response. Many studies 
support the validity of this mechanism, including the encoding 
by all bacteria of HSPs (65). In addition, serum antibodies to 
HSPs are associated with carotid artery thickening, and serum 
antibodies to HSPs of E. coli and Cp are cytotoxic to vascular 
endothelial cells (65). It is also possible that viruses can evoke an 
HSP autoimmune response (64). An additional immune-based 
mechanism by which infectious pathogens may contribute to 
atherosclerosis is via toll-like receptors (TLRs). Pathogens can 
increase expression of TLRs and engender a chronic inflamma-
tory response (65).
Infections and inflammation can have complex influences 
on lipids and lipoproteins (67). The most common influences 
are decreases in serum high density lipids and increases in tri-
glycerides. The greater the severity of inflammation, the greater 
the abnormalities in lipids and inflammation. The underlying 
mechanisms are not clear.
Infections leading to vascular inflammation appear to have the 
capacity to influence risk factors associated with atherosclerosis.
infections and Diet
There may be a connection between food consumption patterns, 
infection, and atherosclerosis. However, the evidence is very 
limited. Studies based on experimental animals suggest that the 
influence of infectious pathogens may differ according to the spe-
cific pathogen, the experimental animal, and type and quantity 
of food. Fabricant et al. demonstrated that Marek’s herpes virus 
leads to atherosclerosis in both hypercholesterolemic and normo-
cholesterolemic chickens (24). Similarly, P. gingivalis bacteremia 
has been shown to induce coronary and aortic atherosclerosis in 
both normocholesterolemic and hypercholesterolemic pigs (72). 
Turkay et al. demonstrated that in experimental rats, a combina-
tion of a high cholesterol diet and infection with Pseudomonas 
aeruginosa led to significantly greater arterial wall thickness than 
either infection or cholesterol diet administered alone (73). There 
are several experimental animal-based studies, which suggest 
that Cp is a risk factor for atherosclerosis in conjunction with 
hyperlipidemia (66).
There is limited relevant evidence in humans. Amazon forage 
horticultural people have high loads of infection, but low adipos-
ity and virtually no arterial degeneration and ACAD (74, 75). 
These observations suggest that infections alone may not cause 
atheroma in humans, and that “excess” food and nutrition plus 
infectious pathogens are also required. A precise definition of 
“excess” nutrition is not possible, but the average daily consump-
tion of food in Western populations is over twice that of Amazon 
villagers (75).
infectious Pathogens, inflammation, and 
lipid Metabolism
Because of the important role of lipids in vascular atherosclerosis, 
the role of specific infectious pathogens in the disruption and 
influence on lipid metabolism is relevant to the search for the 
underlying causes of atheroma (67). In Table 3, potential patho-
gens are listed together with their known influences on human 
and animal lipid metabolism.
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Human Immunodeficiency Virus
The influence of HIV to increase the risk of ACAD has been 
studied in detail. Chronic HIV infections are associated with 
abnormal lipid metabolism, which in turn is associated with 
increased ACAD (36, 76).
Chlamydia pneumonaie
Chlamydia pneumonaie disrupts lipid metabolism in human 
umbilical vein endothelial cells and is associated with increased 
levels of total cholesterol in these cells (77). Cp-infected carotid 
artery macrophage foam cells contain abnormally high low 
density lipoproteins (78). Cp infections trigger the formation 
of lipid-laden foamy macrophages, as seen in atheromatous 
plaques (79). Cp-infected mice show significantly increased 
serum cholesterol and triglyceride levels compared to controls 
(80). Cp infections accelerate the development of atherosclerotic 
lesions in experimental mice fed with high-fat diets (81).
Porphyromonas gingivalis
Chronic oral infection with P. gingivalis accelerates atheroma for-
mation by altering lipid metabolism (82). In addition, P. gingivalis 
increases lipid accumulation in foam cells (83).
Epstein–Barr Virus
Acute infection with EBV is associated with atherogenic lipid 
changes (30). EBV may also be involved in the inflammatory and 
autoimmune processes associated with atherosclerosis (84).
Hepatitis C alters host cell lipid metabolism (85).
Human CMV infections influence host cell sphingolipids and 
lipid metabolism (86, 87).
Helicobacter pylori influences serum lipids and appears to be 
associated with ACAD (88).
Herpes viruses influence arterial accumulation of 
 cholesterol (29).
Human papilloma virus influences intracellular lipids (89).
Human immunodeficiency virus influences lipid metabolism 
and increases cardiovascular disease (90).
ReASONS FOR THe DRAMATiC DeCliNe 
iN ATHeROSCleROSiS AND THe FAll 
iN DeATHS DUe TO ATHeROSCleROTiC 
CORONARY ARTeRY DiSeASe
Determining the etiology of atherosclerosis is a complex task. 
Therefore, it is helpful to consider Karl Popper’s concept of falsifi-
ability or refutability of the hypotheses outlined in this review 
(91). These hypotheses will be nullified or falsified if they are 
shown to be invalid or false.
The decline in the prevalence of deaths due to ACAD during 
the past 50  years is extraordinary. A range of reasons for this 
dramatic decline have been offered (92). These include reductions 
in total serum cholesterol (24%), tobacco smoking (12%), blood 
pressure (20%), and physical activity (5%) plus treatments associ-
ated with revascularization (15%), heart failure (9%), and other 
therapies (12%) (92). These explanations are well documented 
and appear to be valid. Importantly, none of these risk factors are 
relevant in infants, children, and young adults, among some of 
whom atheroma can be well established before the age of 22 years 
(12, 17, 18). There must be additional explanations.
Food
While total excess energy consumption is associated with the 
formation of vascular atheroma, there is limited evidence to sup-
port the hypothesis that saturated or other dietary components 
are major contributors. The substantial increases in consumption 
by US citizens during the past 50 years, of all types of fats, pro-
teins, and to some extent sugars, is the opposite of what would be 
expected with such a dramatic decline in vascular atheroma. This 
is in accord with Popper’s concept of falsification.
Tobacco
There has been a substantial decline in tobacco smoking by US 
citizens during the past 50 years. Forty-two percent of US adults 
smoked tobacco in 1965, and this had fallen to 19% in 2011 (93). 
It is likely that this has contributed to the decline in deaths due 
to coronary artery disease due to atherosclerosis, thrombosis, 
and coronary occlusion (94). However, this decline in tobacco 
smoking is unlikely to be a major factor in the substantial decline 
in atheroma in young soldiers (because of their extremely young 
average age) (12). Again, this is in accord with Popper’s concept 
of falsification.
Hypertension
There is strong evidence that population-wide control of hyper-
tension has resulted in a decline in deaths due to coronary artery 
disease (92). High blood pressure was associated with coronary 
atheroma in 43% of the US soldiers (although the numbers of 
soldiers with hypertension was small and unlikely to be present 
in the young soldiers and is again in accord with Popper’s concept 
of falsification) (12). The prevalence of hypertension among US 
adults has fallen and then risen during the past 50 years (95). It 
is arguable that the control of hypertension has contributed to 
the decline in atheroma, but given the rise in the prevalence of 
hypertension in the US over the past 30 years, this is doubtful.
Statins
Statins have been widely available for the past 25 years. Statins 
can lower blood lipids by up to 50% and significantly reduce ath-
erosclerotic plaques and have been shown to significantly reduce 
ACAD (96). The use of statins has illustrated the important asso-
ciations between blood lipids and cardiovascular disease (96). 
However, the introduction of statins is relatively recent and well 
after the decline in coronary atheroma and ACAD. Importantly, 
statins are not prescribed for young adults and cannot have had 
a role in the reduction of coronary atheroma in this age group. 
Again, this is in accord with Popper’s concept of falsification.
Antibiotics and vaccines
Antibiotics and viral vaccines against a range of infectious dis-
eases began to be used on a population-wide basis in the post 
World War II years. There is no direct evidence that antibiotics 
and viral vaccines have had an influence on atherosclerosis in 
humans, but it a plausible explanation as both have been shown to 
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reduce atheroma in experimental animals (26, 97, 98). A major-
ity of children have been exposed to antibiotics following their 
widespread use since the 1950s. Many types of bacteria that have 
been identified in human blood vessels are sensitive to antibiot-
ics, although bacteria, such as Cp, are less sensitive but can be 
controlled by broad spectrum antibiotics.
There is a major impact on the commensural gut bacteria 
(the gut microbiota) by broad spectrum antibiotics (99, 100). 
Different antibiotics have different influences on specific compo-
nents of the gut microbiota (99). The influence of antibiotics is 
well illustrated by the impact of maternal intrapartum antibiotics 
on gut microbiota, which persist during the first year of life (48). 
In experimental animals, antibiotics have been shown to alter 
bacterial composition and short-chain fatty acids in the cecum 
(100). Experiments on mice have demonstrated that antibiotics 
change the gut microbiota, which in turn lead to improvements 
in glucose tolerance, reduced plasma lipopolysaccharides, and 
altered hepatic and intestinal genes involved in inflammation 
(98). While the evidence is very limited, it is possible that 
antibiotics have an influence on gut microbiota, which in turn 
may have an influence on blood lipids and consequently on 
atherosclerosis.
It is also possible that vaccines against viral infections may 
prevent atheromatous processes. This hypothesis is based on the 
use of vaccines against Marek’s herpes virus, which was shown to 
prevent herpes-induced atheroma in chickens by Fabricant and 
Fabricant (26).
As outlined above, several viruses, including noroviruses, 
mouse mammary tumor virus, poliomyelitis virus, and reovirus, 
each require the co-location of bacteria in the gut to allow these 
viruses to enter cells (49). There is experimental evidence that 
when these viruses were exposed to antibiotics that inhibited gut 
bacteria, these viruses could not enter the target cells (49). This 
is relevant to the hypothesis that antibiotics and vaccines may 
independently be the reasons for the decline in the prevalence of 
atherosclerosis.
CONClUSiON
There has been a substantial (70% among young people) decline in 
atherosclerosis of the coronary arteries during the past 50 years. 
There has been an equivalent decline in deaths due to ACAD in 
Western countries. Despite these declines, ACAD remains as the 
most common cause of death in all continents except Africa. The 
reasons for these declines are not clear. A plausible, but unproven, 
explanation is the widespread introduction of antibiotics and vac-
cines in the post second world war years.
While food and nutrition are important influences on athero-
sclerosis, there is mounting evidence that infectious pathogens 
may initiate atherosclerosis. These influences commence in 
infancy and childhood, and atherosclerosis can be well established 
in some children as young as 12 years of age and in otherwise 
fit young adults. Many pathogens influence lipid metabolism, 
for example Marek’s herpes virus, can cause atherosclerosis 
in experimental chickens in the absence of atherogenic diets. 
Multiple pathogens can infect both the normal and atheroscle-
rotic vascular system, including the aorta and coronary arteries, 
having adverse influences on the endothelial lining and smooth 
muscle cells of blood vessel walls leading to inflammation.
There is evidence, which is not conclusive, that the herpes 
viruses, Cp, P. gingivalis, and Enterobacter coli may be the most 
influential pathogens associated with atherosclerosis.
The search for the causes of ACAD has been dominated by 
research into the influence of food and nutrition. It is timely to 
redirect research efforts.
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